Skip to content
Screener

Shares (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.9%
Stryker logo
StrykerSYK
386M-0.1%
PDE
Pro-Dex, Inc.PDEX
3.3M-2.0%
CONMED logo
CONMEDCNMD
30.1M-3.0%
Vericel logo
VericelVCEL
52.3M+3.9%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
29.5M+6.6%

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$18.17B-0.6%
Enterprise value$25.22B-0.3%
P/E23.9×+1.7×
P/S2.2×-0.2×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 5:11 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-201710
Line itemThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
Less: Net earnings attributable to noncontrolling interest0.20.6
Net Earnings of Zimmer Biomet Holdings, Inc.$238.1$182.0
Earnings Per Common Share
Basic$1.22$0.92
Diluted$1.22$0.91
Weighted Average Common Shares Outstanding
Basic195.0198.9
Diluted195.8199.7

Item 1. Financial Statements

FAQ

What is Zimmer Biomet Holdings's shares (diluted)?
Zimmer Biomet Holdings (ZBH) reported shares (diluted) of 195.8M in Q1 2026.
How has Zimmer Biomet Holdings's shares (diluted) changed year-over-year?
Zimmer Biomet Holdings's shares (diluted) decreased by 2.0% year-over-year, from 199.7M to 195.8M.
What is the long-term trend for Zimmer Biomet Holdings's shares (diluted)?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's shares (diluted) has grown at a -1.4% compound annual growth rate (CAGR), from 841.9M to 795.5M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Zimmer Biomet Holdings's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude